Edition:
India

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

63.78USD
19 Jul 2018
Change (% chg)

$-0.97 (-1.50%)
Prev Close
$64.75
Open
$64.68
Day's High
$64.95
Day's Low
$63.52
Volume
1,545,014
Avg. Vol
1,663,304
52-wk High
$65.50
52-wk Low
$48.06

Latest Key Developments (Source: Significant Developments)

Abbott Laboratories Says Redeemed $1.3 Bln Of $1.8 Bln Outstanding Aggregate Principal Amount Of 2.35% Notes
Saturday, 23 Jun 2018 

June 22 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES SAYS REDEEMED $1.30 BILLION OF $1.80 BILLION OUTSTANDING AGGREGATE PRINCIPAL AMOUNT OF ITS 2.350% NOTES DUE 2019 - SEC FILING.  Full Article

Abbott Laboratories Says Launched Its Afinion 2 Analyzer In U.S.
Thursday, 31 May 2018 

May 31 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES - LAUNCH OF ITS AFINION 2 ANALYZER IN U.S..  Full Article

Abbott Laboratories Says Shareholders Rejected Proposal Requesting Board Of Directors Adopt Policy That Board Chairman Be Independent Director
Tuesday, 1 May 2018 

April 30 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES SAYS SHAREHOLDERS REJECTED PROPOSAL REQUESTING CO'S BOARD OF DIRECTORS ADOPT POLICY THAT BOARD CHAIRMAN BE INDEPENDENT DIRECTOR.  Full Article

Abbott Laboratories - Co, Sanquin Sign Multiple-Year Contract For Supply Of Primary Serological Equipment And Consumables
Monday, 23 Apr 2018 

April 23 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES - CO, SANQUIN SIGN MULTIPLE-YEAR CONTRACT FOR SUPPLY OF PRIMARY SEROLOGICAL EQUIPMENT AND CONSUMABLES.  Full Article

Abbott Initiates Groundbreaking Study To Assess Superiority Of High-Resolution Imaging Versus Standard-Of Care Angiography In Treating Coronary Artery Disease
Wednesday, 11 Apr 2018 

April 11 (Reuters) - Abbott Laboratories ::CARE ANGIOGRAPHY IN TREATING CORONARY ARTERY DISEASE.RESOLUTION IMAGING RESULT IN LARGER VESSEL DIAMETERS.  Full Article

Mylan To Complete $1 Billion Share Repurchase Plan
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Mylan Nv ::MYLAN TO COMPLETE $1 BILLION SHARE REPURCHASE PLAN.MYLAN - AS PER AGREEMENT WITH ABBOTT RELATED TO ABBOTT EPD DEAL, ABBOTT NOTIFIED MYLAN IT SOLD REMAINING 20.3 MILLION IN MYLAN SHARES PRIOR TO YEAR-END​.  Full Article

Abbott gets New FDA Labeling For Some Of Its MRI-Ready Devices
Wednesday, 3 Jan 2018 

Jan 3 (Reuters) - Abbott Laboratories ::NEW FDA MR-CONDITIONAL LABELING APPROVALS FURTHER EXPAND ABBOTT'S PORTFOLIO OF MRI-READY DEVICES.  Full Article

Abbott Increases Quarterly Dividend To 28 Cents Per Share
Friday, 15 Dec 2017 

Dec 15 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES - INCREASED COMPANY'S QUARTERLY COMMON DIVIDEND TO 28 CENTS PER SHARE FROM 26.5 CENTS PER SHARE.  Full Article

Abbott gets FDA clearance for its Alinity ci-series instruments
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Abbott Laboratories :Abbott announces FDA clearance for its Alinity ci-series next-generation diagnostic systems.Abbott laboratories - ‍secured U.S. FDA 510(k) clearance for its alinity ci-series instruments for clinical chemistry and immunoassay diagnostics​.  Full Article

Abbott says ‍secured FDA clearance for confirm Rx Insertable Cardiac Monitor​
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Abbott Laboratories :Abbott - ‍secured FDA clearance for confirm Rx Insertable Cardiac Monitor​.  Full Article

Photo

Abbott Labs raises 2018 earnings forecast, shares hit record high

Abbott Laboratories raised its full-year earnings forecast and topped estimates for quarterly profit on Wednesday, powered by demand for its glucose monitoring device for diabetics and gains from its multibillion dollar acquisitions.